Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G H Pelton

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Archives of General Psychiatry|July 22, 1998
A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disordersC J McDougle, J P Holmes, D C Carlson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 5, 1997
Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjectsL H Price, A Cappiello, R T Malison, et al.
The American Journal of Psychiatry|December 1, 1995
Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorderC J McDougle, L C Barr, W K Goodman, et al.
International Journal of Peptide and Protein Research|December 1, 1988
Novel linear antagonists of the antidiuretic (V2) and vasopressor (V1) responses to vasopressinM Manning, W A Klis, M Kruszynski, et al.
Nature|October 4, 1987
No requirements of cyclic conformation of antagonists in binding to vasopressin receptorsM Manning, J P Przybylski, A Olma, et al.
The American Journal of Psychiatry|August 31, 2000
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-upD P Devanand, K S Michaels-Marston, X Liu, et al.
The American Journal of Psychiatry|November 13, 1998
A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's diseaseD P Devanand, K Marder, K S Michaels, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 3, 1998
Tryptophan depletion during continuous CSF sampling in healthy human subjectsL L Carpenter, G M Anderson, G H Pelton, et al.
Neurology|March 14, 2007
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer diseaseD P Devanand, G Pradhaban, X Liu, et al.
Translational Psychiatry|December 10, 2015
Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [¹¹C]ABP688C DeLorenzo, J Sovago, J Gardus, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Archives of General Psychiatry|July 22, 1998
A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disordersC J McDougle, J P Holmes, D C Carlson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 5, 1997
Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjectsL H Price, A Cappiello, R T Malison, et al.
The American Journal of Psychiatry|December 1, 1995
Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorderC J McDougle, L C Barr, W K Goodman, et al.
International Journal of Peptide and Protein Research|December 1, 1988
Novel linear antagonists of the antidiuretic (V2) and vasopressor (V1) responses to vasopressinM Manning, W A Klis, M Kruszynski, et al.
Nature|October 4, 1987
No requirements of cyclic conformation of antagonists in binding to vasopressin receptorsM Manning, J P Przybylski, A Olma, et al.
The American Journal of Psychiatry|August 31, 2000
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-upD P Devanand, K S Michaels-Marston, X Liu, et al.
The American Journal of Psychiatry|November 13, 1998
A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's diseaseD P Devanand, K Marder, K S Michaels, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 3, 1998
Tryptophan depletion during continuous CSF sampling in healthy human subjectsL L Carpenter, G M Anderson, G H Pelton, et al.
Neurology|March 14, 2007
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer diseaseD P Devanand, G Pradhaban, X Liu, et al.
Translational Psychiatry|December 10, 2015
Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [¹¹C]ABP688C DeLorenzo, J Sovago, J Gardus, et al.
Pageof 3